Abstract
954P - SPAZO2 (SOGUG): Outcomes and prognostic significance of IMDC intermediate prognosis subclassification in metastatic renal cell carcinoma (mRCC) in patients treated with 1st-line pazopanib (1stPz)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have